According to the statistics of Lei Feng. Com, 39 China scholars were elected, accounting for 25%.
AIMBE Fellow is one of the highest professional honors in the fields of medicine and bioengineering.
At present, AIMBE Fellow members include three Nobel Prize winners, 18 members who won the Presidential Medal for Science and Technology Innovation, 20/kloc-0 members of the National Academy of Engineering,/kloc-0 members of the National Academy of Engineering and 45 members of the National Academy of Sciences.
The following is a list of scholars working in domestic units:
Chen Xuesi
Chen Xuesi, academician of China Academy of Sciences, executive deputy director of Academic Committee of Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, doctoral supervisor, deputy director of Academic Committee of Key Laboratory of Eco-environmental Polymer Materials, China Academy of Sciences, and leader of research group of biopolymers.
1988 After graduating from Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, he worked in the institute, obtained his doctorate from Waseda University, and conducted postdoctoral research at the University of Pennsylvania, USA.
From 65438 to 0999, Chen Xuesi returned to Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, and worked as a researcher and doctoral supervisor successively, engaged in the research and development of biodegradable medical polymer materials, tissue engineering and drug sustained release, and the industrialization of polylactic acid and polycaprolactone.
On 20 16, Chen Xuesi was elected as a member of the International Federation of Biomaterials and Engineering, and on 20 19, he was elected as an academician of China Academy of Sciences.
As the project leader, Chen Xuesi has undertaken the key projects of the "Thirteenth Five-Year Plan" of the Ministry of Science and Technology and the basic research center project of the National Natural Science Foundation. In cooperation with Zhejiang Haizheng Group, the industrialization of 6.5438+0.5 million tons of polylactic acid has been realized, and the technical level has reached the international leading level.
Reason for selection: To contribute to the development of gene and drug delivery, nano-medicine, tissue engineering and large-scale production and commercialization of biodegradable polymers.
Ma Guanghui
Ma Guanghui, academician of China Academy of Sciences, researcher and doctoral supervisor of Institute of Process Engineering of China Academy of Sciences, director of State Key Laboratory of Biochemical Engineering of Institute of Process Engineering of China Academy of Sciences, director of National Research Center of Biochemical Engineering Technology (Beijing), vice chairman of China Particle Society, vice chairman of Biochemical Professional Committee of China Chemical Industry Society and director of China Bioengineering Society.
1984, Ma Guanghui went to gunma university to study abroad and obtained a bachelor's degree in fiber polymer engineering. 1990 and 1993 obtained the master's degree and doctor's degree in polymer engineering in tokyo institute of technology respectively.
After receiving his Ph.D., Ma Guanghui worked as an assistant professor in the Department of Applied Science of Biological Systems at A&M University in Tokyo. 200 1 After returning to China, he was selected into the "Hundred Talents Program" of China Academy of Sciences and served as a researcher and doctoral supervisor of Institute of Process Engineering of China Academy of Sciences.
After returning to China, Ma Guanghui mainly engaged in the preparation of homogeneous biological microspheres and microcapsules and their applications in biochemical engineering and medical engineering, and developed innovative products such as protein/vaccine separation medium, sustained and controlled release drug carrier, immune adjuvant (vaccine delivery system), cell culture microcarrier and enzyme immobilized carrier.
According to the Institute of Process Engineering of Chinese Academy of Sciences, Ma Guanghui * * * has obtained 88 domestic invention patents and 2 international patents/kloc-0, and its patented technology and products have been applied in more than 500 units at home and abroad.
Reason for selection: Through innovative membrane emulsification technology and particle system design of biomedical formula, it has made contributions to bioengineering.
Nie guangjun
Nie Guangjun, Distinguished Researcher of China Academy of Sciences, distinguished professor of National Science and Technology University, Chief Scientist of National Major Scientific Research Program of Nano-research of Ministry of Science and Technology, Chief Scientist of National Key R&D Program, Executive Director of China Biophysics Society, Member of Nano-tumor Professional Committee of China Anti-cancer Association and Nano-medicine Professional Committee of China Pharmaceutical Association.
In 2002, Nie Guangjun received his Ph.D. from the Institute of Biophysics, Chinese Academy of Sciences, and then engaged in postdoctoral research at McGill University, Canada.
After returning to China in 2008, the laboratory of "Nanobiology and Nanobiomaterials" was established in the National Nanoscience Center, and a multidisciplinary research team was established. The research fields mainly include tumor nanobiology, nanobiotechnology and nanobiological effects.
According to the data of National Nanoscience Center, Nie Guangjun * * * applied for more than 40 related invention patents (20 granted by China, 3 granted by the United States, 2 granted by Japan 1, and 2 transferred).
Reason for selection: He has made outstanding contributions to the research and development of nano-drugs and intelligent anti-tumor nano-robots in tumor microenvironment.
Gao weiqiang
Gao Weiqiang is currently Professor Wang Kuancheng of Shanghai Jiaotong University, doctoral supervisor, director of State Key Laboratory of Oncogenes and Related Genes, dean of School of Biomedical Engineering, vice president of Med-X Research Institute, and director of stem cell research center of Med-X- Renji Hospital.
1982, Gao Weiqiang graduated from Nanjing University. In the same year, he entered China Academy of Sciences as a graduate student and was selected for CUSBEA program. 1983 went to the United States, and 1989 received a doctorate from Columbia University. He completed postdoctoral research at Columbia University School of Medicine and Rockefeller University. 1993-20 10 served as a scientist/laboratory director and senior scientist of Genentech company in the United States. In 2003, he was awarded "Outstanding Overseas Youth" by the National Natural Science Foundation of China.
20 10 returned home full-time. Director, Stem Cell Research Center, Yan Chai Hospital. At present, it undertakes the national key scientific research plan projects of the Ministry of Science and Technology and the key and general projects of the National Natural Science Foundation. He is also the head of the key discipline of oncology in Shanghai Education Commission and the head of the key discipline of clinical oncology in Shanghai Health Planning Commission.
Gao Weiqiang has long been committed to the mechanism research of "stem cells and tissue development and repair" and "tumor occurrence and development (including tumor stem cells)". In recent years, he has mainly devoted himself to the exploration of tumor stem cells, drug resistance, diagnosis and targeted therapy, as well as the research on nerve injury repair and inner ear hair cell development and regeneration.
Reason for selection: To contribute to stem cells, tissue regeneration and translational medicine of degenerative diseases and tumor stem cells.
cici
Zhang Can, Dean of the Institute of Pharmaceutical Science, China Pharmaceutical University, is a doctoral supervisor and director of the research center of high-end pharmaceutical preparations and materials. He is also the deputy editor-in-chief of biomaterial science, the magazine of Royal Chemical Society, the standing member of Biomedical Composites Branch of China Composite Materials Society, the member of Nano-medicine Professional Committee of China Pharmaceutical Society, the member of Academic Committee of Tianjin Key Laboratory of Clinical Medicine, the editorial board of Journal of China Pharmaceutical University, and the member of Academic Committee of China Pharmaceutical University.
1986, Zhang Can obtained a bachelor's degree in polymer synthetic materials from the Department of Chemistry of Nanjing University; In 2000, he obtained a master's degree in medicinal chemistry from China Pharmaceutical University. In 2003, he received a doctorate in polymer chemistry and physics from the School of Chemistry and Chemical Engineering of Nanjing University. Since my work, I have been engaged in the research of new medical polymer materials and innovative drugs.
As the project leader, he presided over more than 40 scientific research projects, such as major projects of new drug creation and key technology sub-projects of major projects of new drug creation, key projects of international exchange of Ministry of Science and Technology, 863 Program, key projects of National Natural Science Foundation and key projects of Ministry of Education. Authorized 24 invention patents, translated works 1 department and 3 co-edited works.
Reason for selection: It is helpful for cell therapy and transformation research.
Wang Meiyun
Wang Meiyun, director of Henan Medical Imaging Center. Doctor, chief physician, professor, doctoral supervisor, postdoctoral fellow of Harvard Medical School, visiting professor of Johns Hopkins Medical School, the first certified lecturer of the International Magnetic Vibration Society in China, and the first batch of China image lecturers and trainers of the American Radiological Society.
Wang Meiyun's research interests are the imaging diagnosis and research of nervous system diseases and the application of new magnetic vibration technology. Editor-in-Chief 1 Medical Imaging English Course, and participated in 8 monographs. In recent years, he has successively won the honorary titles of national outstanding scientific and technological workers, academic and technological leaders in Henan Province, outstanding young scientific and technological experts in Henan Province, and special allowance experts of Henan Provincial Government.
Reason for selection: To contribute to exploring and expanding the value of multi-mode imaging technology in improving the diagnosis and treatment of diseases.
Tang qiyu
Tang Qiyu is an academician of the American Society of Medical and Bioengineering, a founding member of the Hong Kong Academy of Youth Sciences, and the head of the Department of Biomedical Engineering of the Chinese University of Hong Kong.
65438-0999 Tang Qiyu received a doctorate in biomedical engineering from the University of Clyde, UK. His research fields include rehabilitation robot, brain-computer interface (BCI), neural engineering, functional electrical stimulation (FES) and stroke rat model.
20 13 won the Top Ten Outstanding Young People (Hong Kong) Award, and the research achievement won the gold medal in the 44th Geneva International Invention Exhibition. 20 16 was invited to give a technical report at Davos Forum.
Reason for selection: To develop the "Hand of Hope" upper limb rehabilitation instrument for stroke rehabilitation, and establish the first department of biomedical engineering in Hong Kong.
Yao Jianhua
Yao Jianhua, chief scientist of Tencent AI Lab AI Medical, holds a bachelor's degree in computer science from Tianjin University, a master's degree in computer science from Tsinghua University and a doctorate in computer science from Johns Hopkins University.
Yao Jianhua has made outstanding achievements in precision medicine, image analysis, pathological image processing, tumor growth prediction and surgical navigation. At the same time, Yao Jianhua is also the deputy editor-in-chief of IEEE JBHI, responsible for editing many AI image special issues and regional chairs of AI summits, and organizing many international academic seminars on medical imaging. He has published more than 350 papers in international journals and summits, and has been cited more than 14000 times, with an h-index of 47.
Since joining Tencent AI Lab, Yao Jianhua has led the team to release a number of research and application results, including the first intelligent microscope approved for clinical application in China; Provide technology and solutions for Tencent's national image product "Tencent Looking for Shadows"; The severe disease prediction model developed by COVID-19 and Zhong Nanshan team was published in Nature News and used in more than 80 countries around the world. In the future, Yao Jianhua will also lead the team to develop in the direction of AI+ life science.
Reason for selection: It is helpful to the research, clinical service and commercial development of biomedical image analysis and artificial intelligence medical care.
The list of all selected China people is as follows:
Chen Xuesi of China Academy of Sciences
Ma Guanghui of China Academy of Sciences
Nie Guangjun, National Nanotechnology Center
Gao Weiqiang of Shanghai Jiaotong University
China Pharmaceutical University Zhang Can Campus
Wang Meiyun, Dean of Henan Provincial People's Hospital.
Tang Qiyu of the University of Hong Kong
Tencent Artificial Intelligence Laboratory Yao Jianhua
Abbott Qiao Qiao Ruan
Albert Tao Xin
University of Delaware at Wang Liyun
beth israel deaconess medical center
Hao Fuzhang, Northwestern University, USA
Pan Zheng of OncoC4 Company
Zhu Kun, Washington University in St. Louis
Siemens medical sharp material
Carnegie Mellon University, Ma Jian.
Chen, University of Houston
University of Oklahoma
Wilfred Chen, University of Delaware
Chen Youhai, University of Pennsylvania
Cheng Jianlin, University of Missouri-Columbia
Jiao Rongzhi of Southern Methodist University
Zhao Hua Ding of Vanderbilt University
Dong Yizhou, Ohio State University
Jean Gao, University of Texas at Arlington
Han Gang, University of Massachusetts Medical College.
Boston University, Cecilia Han
Texas a & amp； The season of m university
Steve Jiang, Southwest Medical Center, University of Texas
Li Yuanpei, University of California, Davis
University of California, Irvine, Liu Chang
University of California, Berkeley, Liu Chunlei
Wendy Liu, University of California, Irvine
Dana Farber Cancer Institute affiliated to Harvard Medical School.
University of Illinois at Lu Ting
Ren Dacheng of Syracuse University
Stephen T. Wong of Houston Methodist Hospital
Wu Nianqiang, University of Massachusetts at amherst.